| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |